NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 981 filers reported holding NOVARTIS A G in Q2 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $5,544,000 | +8.3% | 58,525 | -0.6% | 0.04% | 0.0% |
| Q3 2019 | $5,119,000 | -2.4% | 58,869 | +2.6% | 0.04% | -5.0% |
| Q2 2019 | $5,244,000 | +0.8% | 57,401 | +6.1% | 0.04% | -7.0% |
| Q1 2019 | $5,201,000 | +19.9% | 54,088 | +7.1% | 0.04% | 0.0% |
| Q4 2018 | $4,336,000 | +9.5% | 50,508 | +9.9% | 0.04% | +7.5% |
| Q3 2018 | $3,961,000 | +39.7% | 45,971 | +22.5% | 0.04% | +2.6% |
| Q2 2018 | $2,836,000 | -21.6% | 37,541 | -16.1% | 0.04% | -22.0% |
| Q1 2018 | $3,618,000 | -27.4% | 44,720 | -24.6% | 0.05% | -25.4% |
| Q4 2017 | $4,982,000 | +32.1% | 59,328 | +35.1% | 0.07% | +13.6% |
| Q3 2017 | $3,771,000 | +14.1% | 43,905 | +11.0% | 0.06% | +1.7% |
| Q2 2017 | $3,305,000 | +5.1% | 39,571 | -6.6% | 0.06% | -9.4% |
| Q1 2017 | $3,146,000 | +7.3% | 42,368 | +5.3% | 0.06% | -3.0% |
| Q4 2016 | $2,933,000 | +11.0% | 40,245 | +20.3% | 0.07% | +3.1% |
| Q3 2016 | $2,642,000 | +6.9% | 33,457 | +11.5% | 0.06% | -1.5% |
| Q2 2016 | $2,472,000 | – | 30,014 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |